To apply for Class D medical device registration under the MDACS (Medical Device Administrative Control System) in Hong Kong, you must meet a series of regulatory, technical, and procedural requirements. Class D represents the highest-risk category, including life-supporting, implantable, or critical treatment devices (e.g., pacemakers, heart valves, dialysis systems).
Below is a detailed list of requirements for Class D medical device MDACS registration in Hong Kong:
Must be appointed if the manufacturer is not based in Hong Kong.
Must be a registered business in Hong Kong.
The LRP is responsible for:
Submitting the MDACS application
Post-market surveillance
Vigilance reporting (e.g. adverse events, recalls)
Communication with the Medical Device Division (MDD)
You must confirm your device is Class D using:
Technical Reference TR-003 (for general medical devices)
Technical Reference TR-006 (for IVD devices)
Class D includes:
Devices in direct contact with the heart or central circulatory system
Devices that sustain life or prevent life-threatening conditions
Implantable and critical devices
MD 1 Form for general medical devices
MD 100 series for IVDs (if applicable)
Must be submitted via the MDIS online system (paper applications no longer accepted after October 2024)
Must show compliance with Essential Principles of Safety and Performance (see GN-01 and GN-02)
Includes a signed statement from the manufacturer
You must provide:
Certificate of Free Sale (CFS) or equivalent approval from at least one of the following:
EU (CE certificate)
USA (FDA 510(k) or PMA)
Canada (Health Canada MDL)
Australia (TGA ARTG)
Japan (PMDA or MHLW)
China (NMPA)
South Korea (MFDS)
Singapore (HSA)
Valid ISO 13485:2016 certificate issued by an accredited notified body
QMS must cover the entire production process for the device
Must comply with ISO 14971
Should include:
Risk analysis
Mitigation strategies
Residual risk evaluation
Required for high-risk Class D devices
Can include:
Clinical trials
Literature review
Equivalence to existing approved devices
Device description (design, mechanism of action, components)
Manufacturing process overview
Software documentation (if applicable)
Sterilization process details (if applicable)
Must be in English and/or Traditional Chinese
Include:
Intended use
Contraindications
Warnings and precautions
Manufacturer and LRP details
UDI (if applicable)
Must describe:
Monitoring procedures
Adverse event reporting system
Field safety corrective action (FSCA) plan
Device recall procedures
Customer complaint handling system
Depending on device type:
Biocompatibility testing results (per ISO 10993)
Electrical safety reports (IEC 60601 series)
EMC test reports
Software validation (for software-driven devices)
Sterility and shelf life validation
All documents must be submitted through the MDIS online platform: https://www.mdd.gov.hk
LRP must register an account and manage submissions
| Phase | Estimated Time |
|---|---|
| Initial screening | 2–4 weeks |
| Technical document review | 3–6 months |
| Supplementary information | As needed |
| Listing issuance | Upon approval |
Total timeline may range from 3 to 9 months, depending on complexity and completeness.
| Requirement Type | Description |
|---|---|
| ✅ Local Responsible Person | HK-registered legal entity |
| ✅ Application Form | MD1 (online via MDIS) |
| ✅ Declaration of Conformity | GN-01 / GN-02 principles |
| ✅ Foreign Approval | CFS / CE / FDA / TGA etc. |
| ✅ ISO 13485 QMS | For device manufacture |
| ✅ Risk Management Report | ISO 14971 |
| ✅ Clinical Evaluation | Literature / trials |
| ✅ Technical Documentation | Product design & function |
| ✅ Labeling & IFU | English & Traditional Chinese |
| ✅ PMS Plan | Post-market compliance plan |
Ensure all foreign certificates (FDA/CE) are valid and current
Labeling must match the device model and intended use exactly
Prepare to respond quickly to MDD’s requests for clarification
Maintain traceability from manufacturer to Hong Kong distributor
Retain all documents and distribution records for inspection

Whatsapp or Wechat:+86 15816864648;email address:hito.lin@grzan.cn